149 related articles for article (PubMed ID: 25318053)
1. Preparation and evaluation of human-murine chimeric antibody against protective antigen of Bacillus anthracis.
Hao L; Zheng F; Xiong S; Hu D; Lv H; Tang Q; Yang J; Feng Z; Wang C; Zhu J
Int J Mol Sci; 2014 Oct; 15(10):18496-507. PubMed ID: 25318053
[TBL] [Abstract][Full Text] [Related]
2. A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro.
Ding G; Chen X; Zhu J; Duesbery NS; Cheng X; Cao B
Clin Dev Immunol; 2013; 2013():475809. PubMed ID: 23861692
[TBL] [Abstract][Full Text] [Related]
3. A Novel Chimeric Anti-PA Neutralizing Antibody for Postexposure Prophylaxis and Treatment of Anthrax.
Xiong S; Tang Q; Liang X; Zhou T; Yang J; Liu P; Chen Y; Wang C; Feng Z; Zhu J
Sci Rep; 2015 Jul; 5():11776. PubMed ID: 26134518
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
Little SF; Webster WM; Fisher DE
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
[TBL] [Abstract][Full Text] [Related]
5. Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694.
Laffly E; Danjou L; Condemine F; Vidal D; Drouet E; Lefranc MP; Bottex C; Thullier P
Antimicrob Agents Chemother; 2005 Aug; 49(8):3414-20. PubMed ID: 16048955
[TBL] [Abstract][Full Text] [Related]
6. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
[TBL] [Abstract][Full Text] [Related]
7. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax.
Tang Q; Xiong S; Liang X; Kuai X; Wang Y; Wang C; Feng Z; Zhu J
BMC Infect Dis; 2018 Dec; 18(1):640. PubMed ID: 30526504
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
Park YS; Lee JH; Hung CF; Wu TC; Kim TW
Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494
[TBL] [Abstract][Full Text] [Related]
11. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
Dumas EK; Nguyen ML; Cox PM; Rodgers H; Peterson JL; James JA; Farris AD
Vaccine; 2013 Apr; 31(14):1856-63. PubMed ID: 23415781
[TBL] [Abstract][Full Text] [Related]
12. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
[TBL] [Abstract][Full Text] [Related]
13. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.
Lim NK; Kim JH; Oh MS; Lee S; Kim SY; Kim KS; Kang HJ; Hong HJ; Inn KS
Infect Immun; 2005 Oct; 73(10):6547-51. PubMed ID: 16177329
[TBL] [Abstract][Full Text] [Related]
14. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
[No Abstract] [Full Text] [Related]
15. Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody.
Chen Z; Moayeri M; Crown D; Emerson S; Gorshkova I; Schuck P; Leppla SH; Purcell RH
Infect Immun; 2009 Sep; 77(9):3902-8. PubMed ID: 19528217
[TBL] [Abstract][Full Text] [Related]
16. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
Moayeri M; Leysath CE; Tremblay JM; Vrentas C; Crown D; Leppla SH; Shoemaker CB
J Biol Chem; 2015 Mar; 290(10):6584-95. PubMed ID: 25564615
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapies against anthrax.
Chen Z; Moayeri M; Purcell R
Toxins (Basel); 2011 Aug; 3(8):1004-19. PubMed ID: 22069754
[TBL] [Abstract][Full Text] [Related]
19. Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.
Pohl MA; Rivera J; Nakouzi A; Chow SK; Casadevall A
Infect Immun; 2013 Jun; 81(6):1880-8. PubMed ID: 23509144
[TBL] [Abstract][Full Text] [Related]
20. A therapeutic human antibody against the domain 4 of the Bacillus anthracis protective antigen shows protective efficacy in a mouse model.
Ahn BE; Bae HW; Lee HR; Woo SJ; Park OK; Jeon JH; Park J; Rhie GE
Biochem Biophys Res Commun; 2019 Feb; 509(2):611-616. PubMed ID: 30606479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
